| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/23/2003 | WO2002044336B1 Method of making a protein polymer and uses of the polymer |
| 10/23/2003 | WO2002044321A3 Rna interference mediating small rna molecules |
| 10/23/2003 | WO2002042465A8 Production of stilbenes in transgenic plants and the method of producing thereof |
| 10/23/2003 | WO2002038811A3 Assay for the detection and quantitation of hemimethylation |
| 10/23/2003 | WO2002036806A3 Expression vectors able to elicit improved immune response and methods of using same |
| 10/23/2003 | WO2002036630A3 Renin and/or proprenin receptor protein, nucleic acid coding for same and uses thereof |
| 10/23/2003 | WO2002036617A3 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 10/23/2003 | WO2002029007A3 Bacteria used for oxidising arsenic, method for selecting same and uses thereof for treating media containing arsenic |
| 10/23/2003 | WO2002020838A3 Method and system for detecting nucleic acids |
| 10/23/2003 | WO2001096376A9 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 10/23/2003 | WO2001068805A3 Human olfactory receptors and genes encoding same |
| 10/23/2003 | WO2001066763A9 23436, a human ubiquitin protease family member and uses thereof |
| 10/23/2003 | WO2001062944A3 Intergenic and intragenic integration sites for foreign gene expression in recombinant s. gordonii strains |
| 10/23/2003 | WO2001055337A9 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 10/23/2003 | WO2001040519A8 Methods for identifying modulators for balance related disorders |
| 10/23/2003 | WO2001029232A8 Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage |
| 10/23/2003 | WO2001009328A8 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 10/23/2003 | WO2001004285A8 Maize msi polynucleotides and methods of use |
| 10/23/2003 | WO2001002567A8 16405 receptor, a g-protein coupled receptor |
| 10/23/2003 | WO2001000879A8 Novel kinases and uses thereof |
| 10/23/2003 | WO2001000812A8 22012, a novel human carboxypeptidase |
| 10/23/2003 | WO2001000811A8 17867, a novel human aminopeptidase |
| 10/23/2003 | US20030200569 Amino acid:glyoxylate aminotransferase genes from plants and uses thereof |
| 10/23/2003 | US20030200568 Plastid transformation in lesquerella fendleri, an oilseed brassica |
| 10/23/2003 | US20030200567 Isolation and identification of a gene encoding the calreticulin -interacting polypeptide (CRTintP) |
| 10/23/2003 | US20030200566 Commercial production of insulin and insulin-like proteins in plants |
| 10/23/2003 | US20030200565 Isolation and use of nucleic acid molecules for control of gene expression in plants, specifically novel plant promoters |
| 10/23/2003 | US20030200564 Starch modification |
| 10/23/2003 | US20030200562 Geminivirus resistant transgenic plants |
| 10/23/2003 | US20030200561 Transgenic plants expressing puroindolines and methods for producing such plants |
| 10/23/2003 | US20030200560 Herbicide resistant plants |
| 10/23/2003 | US20030200558 Enhanced proteins and methods for their use |
| 10/23/2003 | US20030200557 Transcriptional initiation regions/gene expression cassettes isolated from plant genes for actin-2, enolase, Gos-2 genes, and L41 genes; transgenic plants |
| 10/23/2003 | US20030200556 Activation of equine oocytes |
| 10/23/2003 | US20030199684 Novel gene involved in brassinosteroid responses |
| 10/23/2003 | US20030199682 Novel plant expression constructs |
| 10/23/2003 | US20030199681 Novel plant expression constructs |
| 10/23/2003 | US20030199679 Recombinant antibodies specific for TNF-alpha |
| 10/23/2003 | US20030199677 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 10/23/2003 | US20030199676 Effective for proteins expressed in bacteria as inclusion bodies |
| 10/23/2003 | US20030199673 For inducing immune response and administering immunotherapy |
| 10/23/2003 | US20030199516 Methods of treating infection by drug resistant bacteria |
| 10/23/2003 | US20030199472 Administering to the patient an effective amount of an expression construct comprising nucleic acid comprising a sequence encoding a modified estrogen receptor, wherein sequence is under control of promoter |
| 10/23/2003 | US20030199471 For use in medicaments |
| 10/23/2003 | US20030199470 Determining the status of 158P1D7 gene products expressed by cells in a tissue sample; comparing the status so determined to the status of 158P1D7 gene products in normal sample; identifying the presence of aberrant 158P1D7 gene products |
| 10/23/2003 | US20030199468 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences |
| 10/23/2003 | US20030199467 Antisense modulation of human Rho family gene expression |
| 10/23/2003 | US20030199466 For modulating an immune response |
| 10/23/2003 | US20030199464 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 10/23/2003 | US20030199463 For therapy of cardiovascular disease, fibrotic disease |
| 10/23/2003 | US20030199447 Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein |
| 10/23/2003 | US20030199431 Modified peptide nucleic acid (PNA) molecules |
| 10/23/2003 | US20030199423 ICAM-related protein |
| 10/23/2003 | US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides |
| 10/23/2003 | US20030199097 Measurements for a sample on the measuring surfaces of a substrate which makes it possible to simplify the control and construction of a measuring device, shorten the measuring period, make the measuring conditions constant with accuracy |
| 10/23/2003 | US20030199093 Retroviral packaging system, plasmids and packagable vector transcripts produced from high expression plasmids after stable or transient transfection in mammalian cells |
| 10/23/2003 | US20030199092 By increasing level of ribosome receptor |
| 10/23/2003 | US20030199091 Compositions and methods for enhancing oligonucleotide-mediated gene alteration |
| 10/23/2003 | US20030199090 Compositions and methods for drug delivery using pH sensitive molecules |
| 10/23/2003 | US20030199089 Membrane to membrane delivery |
| 10/23/2003 | US20030199088 Minicell-based gene therapy |
| 10/23/2003 | US20030199078 Lysing a biological sample containing an analyte in a reaction vessel, adding a solid adsorption matrix, incubating to bind analyte to the adsorption matrix, removing non-bound components, incubating to elute analyte from the matrix |
| 10/23/2003 | US20030199077 Subtilase variants having an improved wash performance on egg stains |
| 10/23/2003 | US20030199074 Cold-adapted equine influenza viruses |
| 10/23/2003 | US20030199073 Production of recombinant human lysosomal alpha-mannosidase |
| 10/23/2003 | US20030199070 Crystallization of ribosome recycling factor (RRF) and method of developing inhibitor of RRF |
| 10/23/2003 | US20030199067 Growth arrest homeobox gene |
| 10/23/2003 | US20030199064 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199063 PRO polypeptides; fused to heterologous polypeptide sequences |
| 10/23/2003 | US20030199062 PRO polypeptides; fused to heterologous polypeptide sequences |
| 10/23/2003 | US20030199061 PRO polypeptides; fused to heterologous polypeptide sequences |
| 10/23/2003 | US20030199060 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199059 PRO polypeptides; fused to heterologous polypeptide sequences |
| 10/23/2003 | US20030199058 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199057 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199056 PRO polypeptides; fused to heterologous polypeptide sequences |
| 10/23/2003 | US20030199055 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199054 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199053 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199052 PRO polypeptides; fused to heterologous polypeptide sequences |
| 10/23/2003 | US20030199051 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199045 Process for the preparation of L-amino acids with amplification of the zwf gene |
| 10/23/2003 | US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated |
| 10/23/2003 | US20030199042 Novel morphogenic protein |
| 10/23/2003 | US20030199040 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18 |
| 10/23/2003 | US20030199038 Linearized plasmids and the DNA fragments recombine by in vivo recombination to produce a plurality of autonomously replicating plasmids containing one or more variants of the DNA sequence |
| 10/23/2003 | US20030199037 Methods for increasing homologous recombination of a nucleic acid sequence |
| 10/23/2003 | US20030199036 Ubiquitin ligases, and uses related thereto |
| 10/23/2003 | US20030199035 Metabolically engineered lactic acid bacteria and means for providing same |
| 10/23/2003 | US20030199033 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199032 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199031 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences |
| 10/23/2003 | US20030199030 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199029 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences |
| 10/23/2003 | US20030199028 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199027 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199026 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences |
| 10/23/2003 | US20030199025 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences |
| 10/23/2003 | US20030199023 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences |
| 10/23/2003 | US20030199020 Chimeric heteromultimer adhesins |